Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk of Non-melanoma Skin Cancer in Patients with Atopic Dermatitis Treated with Oral Immunosuppressive Drugs.
Garritsen FM, van der Schaft J, van den Reek JM, Politiek K, van Os-Medendorp H, van Dijk M, Hijnen DJ, de Graaf M, Bruijnzeel-Koomen CA, de Jong EM, Schuttelaar MA, Bruin-Weller MS. Garritsen FM, et al. Among authors: schuttelaar ma. Acta Derm Venereol. 2017 Jun 9;97(6):724-730. doi: 10.2340/00015555-2637. Acta Derm Venereol. 2017. PMID: 28218345 Free article.
A survey of members of the European Surveillance System on Contact Allergy and the EU project "StanDerm" to identify allergens tested in cosmetic series across Europe.
Horton E, Wilkinson M, Aalto-Korte K, Pesonen M, Bauer A, Chowdhury MMU, Cooper S, Cousen P, Crépy MN, Larese Filon F F, Gallo R, Geier J, Giménez-Arnau A, Gonçalo M, Goossens A, Green C, Guarneri F, Ljubojević Hadžavdić S, Johansen JD, Johnston GA, Rustemeyer T, Sánchez-Pérez J, Thyssen JP, Schuttelaar MA, Stone N, Uter W. Horton E, et al. Among authors: schuttelaar ma. Contact Dermatitis. 2020 Mar;82(3):195-200. doi: 10.1111/cod.13437. Epub 2020 Jan 3. Contact Dermatitis. 2020. PMID: 31747053
European patch test results with audit allergens as candidates for inclusion in the European Baseline Series, 2019/20: Joint results of the ESSCAA and the EBSB working groups of the ESCD, and the GEIDACC.
Uter W, Wilkinson SM, Aerts O, Bauer A, Borrego L, Buhl T, Cooper SM, Dickel H, Gallo R, Giménez-Arnau AM, John SM, Navarini AA, Pesonen M, Pónyai G, Rustemeyer T, Schliemann S, Schubert S, Schuttelaar MA, Valiukevičienė S, Wagner N, Weisshaar E, Gonçalo M; ESSCA and EBS ESCD working groups, and the GEIDAC. Uter W, et al. Among authors: schuttelaar ma. Contact Dermatitis. 2022 May;86(5):379-389. doi: 10.1111/cod.14059. Epub 2022 Feb 17. Contact Dermatitis. 2022. PMID: 35099073
Strategies used for measuring long-term control in atopic dermatitis trials: A systematic review.
Barbarot S, Rogers NK, Abuabara K, Aubert H, Chalmers J, Flohr C, Hanifin J, Naldi L, Margolis DJ, Paul C, Ridd MJ, Schuttelaar MA, Simpson E, Tauber M, Volke A, Weidinger S, Wilkes SR, Wollenberg A, Thomas KS. Barbarot S, et al. Among authors: schuttelaar ma. J Am Acad Dermatol. 2016 Nov;75(5):1038-1044. doi: 10.1016/j.jaad.2016.05.043. Epub 2016 Aug 10. J Am Acad Dermatol. 2016. PMID: 27522613 Review.
Long-term treatment with 0.1% tacrolimus ointment in adults with atopic dermatitis: results of a two-year, multicentre, non-comparative study.
Reitamo S, Ortonne JP, Sand C, Bos J, Cambazard F, Bieber T, Grønhøj-Larsen C, Rustin M, Fölster-Holst R, Schuttelaar M; European Tacrolimus Ointment Study Group. Reitamo S, et al. Acta Derm Venereol. 2007;87(5):406-12. doi: 10.2340/00015555-0282. Acta Derm Venereol. 2007. PMID: 17721647 Free article. Clinical Trial.
Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study.
Thaçi D, Reitamo S, Gonzalez Ensenat MA, Moss C, Boccaletti V, Cainelli T, van der Valk P, Buckova H, Sebastian M, Schuttelaar ML, Ruzicka T; European Tacrolimus Ointment Study Group. Thaçi D, et al. Among authors: schuttelaar ml. Br J Dermatol. 2008 Dec;159(6):1348-56. doi: 10.1111/j.1365-2133.2008.08813.x. Epub 2008 Sep 6. Br J Dermatol. 2008. PMID: 18782319 Clinical Trial.
26 results